Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gene therapy refers to the introduction of exogenous normal genes into target cells to correct or compensate for diseases caused by defective and abnormal genes in order to achieve therapeutic goals.
In recent years, gene therapy has been used with increased frequency to treat a variety of rare and incurable diseases, such as cancer and genetic disorders. Increased funding for cellular gene therapy companies in European countries such as the UK is expected to drive the European market at a considerable growth rate. Moreover, European companies are committed to expand product distribution globally by obtaining approvals from several regulatory bodies. China is recognized as a global focus for the development of new therapies. In the current scenario, the number of ongoing clinical trials for gene therapies in China has surpassed the number of trials in the US. The Asia-Pacific gene therapy market is also expected to grow.
Gene therapy can provide a fundamental solution to many difficult conditions such as cancer, and with the increasing research in biotechnology, more gene therapies will be found, which is expected to drive the gene therapy market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gene Therapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gene Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Gene Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Dimension Therapeutics
Spark Therapeutics
Celladon
Vical
Avalanche Bio
Advantagene
Sangamo
By Type:
Lentivirus
AAV
Retrovirus & Gammaretrovirus
Modified Herpes Simplex Virus
Adenovirus
Non-viral Plasmid Vector
By End-User:
Acute Lymphoblastic Leukemia (ALL)
Inherited Retinal Disease
Large B-cell Lymphoma
ADA-SCID
Melanoma (Lesions)
Beta-Thalassemia Major/SCD
Head & Neck Squamous Cell Carcinoma
Peripheral Arterial Disease
Spinal Muscular Atrophy (SMA)
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene Therapy Market
-
1.3 Market Segment by Type
-
1.3.1 USA Gene Therapy Market Size and Growth Rate of Lentivirus from 2016 to 2027
-
1.3.2 USA Gene Therapy Market Size and Growth Rate of AAV from 2016 to 2027
-
1.3.3 USA Gene Therapy Market Size and Growth Rate of Retrovirus & Gammaretrovirus from 2016 to 2027
-
1.3.4 USA Gene Therapy Market Size and Growth Rate of Modified Herpes Simplex Virus from 2016 to 2027
-
1.3.5 USA Gene Therapy Market Size and Growth Rate of Adenovirus from 2016 to 2027
-
1.3.6 USA Gene Therapy Market Size and Growth Rate of Non-viral Plasmid Vector from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Gene Therapy Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL) from 2016 to 2027
-
1.4.2 USA Gene Therapy Market Size and Growth Rate of Inherited Retinal Disease from 2016 to 2027
-
1.4.3 USA Gene Therapy Market Size and Growth Rate of Large B-cell Lymphoma from 2016 to 2027
-
1.4.4 USA Gene Therapy Market Size and Growth Rate of ADA-SCID from 2016 to 2027
-
1.4.5 USA Gene Therapy Market Size and Growth Rate of Melanoma (Lesions) from 2016 to 2027
-
1.4.6 USA Gene Therapy Market Size and Growth Rate of Beta-Thalassemia Major/SCD from 2016 to 2027
-
1.4.7 USA Gene Therapy Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma from 2016 to 2027
-
1.4.8 USA Gene Therapy Market Size and Growth Rate of Peripheral Arterial Disease from 2016 to 2027
-
1.4.9 USA Gene Therapy Market Size and Growth Rate of Spinal Muscular Atrophy (SMA) from 2016 to 2027
-
1.4.10 USA Gene Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gene Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gene Therapy by Major Types
-
3.4.1 Market Size and Growth Rate of Lentivirus
-
3.4.2 Market Size and Growth Rate of AAV
-
3.4.3 Market Size and Growth Rate of Retrovirus & Gammaretrovirus
-
3.4.4 Market Size and Growth Rate of Modified Herpes Simplex Virus
-
3.4.5 Market Size and Growth Rate of Adenovirus
-
3.4.6 Market Size and Growth Rate of Non-viral Plasmid Vector
4 Segmentation of Gene Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gene Therapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gene Therapy in Acute Lymphoblastic Leukemia (ALL)
-
4.4.2 Market Size and Growth Rate of Gene Therapy in Inherited Retinal Disease
-
4.4.3 Market Size and Growth Rate of Gene Therapy in Large B-cell Lymphoma
-
4.4.4 Market Size and Growth Rate of Gene Therapy in ADA-SCID
-
4.4.5 Market Size and Growth Rate of Gene Therapy in Melanoma (Lesions)
-
4.4.6 Market Size and Growth Rate of Gene Therapy in Beta-Thalassemia Major/SCD
-
4.4.7 Market Size and Growth Rate of Gene Therapy in Head & Neck Squamous Cell Carcinoma
-
4.4.8 Market Size and Growth Rate of Gene Therapy in Peripheral Arterial Disease
-
4.4.9 Market Size and Growth Rate of Gene Therapy in Spinal Muscular Atrophy (SMA)
-
4.4.10 Market Size and Growth Rate of Gene Therapy in Others
5 Market Analysis by Regions
-
5.1 USA Gene Therapy Production Analysis by Regions
-
5.2 USA Gene Therapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Gene Therapy Landscape Analysis
-
6.1 West USA Gene Therapy Landscape Analysis by Major Types
-
6.2 West USA Gene Therapy Landscape Analysis by Major End-Users
7 South USA Gene Therapy Landscape Analysis
-
7.1 South USA Gene Therapy Landscape Analysis by Major Types
-
7.2 South USA Gene Therapy Landscape Analysis by Major End-Users
8 Middle West USA Gene Therapy Landscape Analysis
-
8.1 Middle West USA Gene Therapy Landscape Analysis by Major Types
-
8.2 Middle West USA Gene Therapy Landscape Analysis by Major End-Users
9 Northeast USA Gene Therapy Landscape Analysis
-
9.1 Northeast USA Gene Therapy Landscape Analysis by Major Types
-
9.2 Northeast USA Gene Therapy Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Dimension Therapeutics
-
10.1.1 Dimension Therapeutics Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Spark Therapeutics
-
10.2.1 Spark Therapeutics Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Celladon
-
10.3.1 Celladon Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Vical
-
10.4.1 Vical Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Avalanche Bio
-
10.5.1 Avalanche Bio Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Advantagene
-
10.6.1 Advantagene Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Sangamo
-
10.7.1 Sangamo Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Gene Therapy Market Size and Growth Rate of Lentivirus from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of AAV from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Retrovirus & Gammaretrovirus from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Modified Herpes Simplex Virus from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Adenovirus from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Non-viral Plasmid Vector from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL) from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Inherited Retinal Disease from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Large B-cell Lymphoma from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of ADA-SCID from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Melanoma (Lesions) from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Beta-Thalassemia Major/SCD from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Peripheral Arterial Disease from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Spinal Muscular Atrophy (SMA) from 2016 to 2027
-
Figure USA Gene Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gene Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gene Therapy
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gene Therapy by Different Types from 2016 to 2027
-
Table Consumption Share of Gene Therapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Lentivirus
-
Figure Market Size and Growth Rate of AAV
-
Figure Market Size and Growth Rate of Retrovirus & Gammaretrovirus
-
Figure Market Size and Growth Rate of Modified Herpes Simplex Virus
-
Figure Market Size and Growth Rate of Adenovirus
-
Figure Market Size and Growth Rate of Non-viral Plasmid Vector
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gene Therapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gene Therapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Acute Lymphoblastic Leukemia (ALL)
-
Figure Market Size and Growth Rate of Inherited Retinal Disease
-
Figure Market Size and Growth Rate of Large B-cell Lymphoma
-
Figure Market Size and Growth Rate of ADA-SCID
-
Figure Market Size and Growth Rate of Melanoma (Lesions)
-
Figure Market Size and Growth Rate of Beta-Thalassemia Major/SCD
-
Figure Market Size and Growth Rate of Head & Neck Squamous Cell Carcinoma
-
Figure Market Size and Growth Rate of Peripheral Arterial Disease
-
Figure Market Size and Growth Rate of Spinal Muscular Atrophy (SMA)
-
Figure Market Size and Growth Rate of Others
-
Table USA Gene Therapy Production by Regions
-
Table USA Gene Therapy Production Share by Regions
-
Figure USA Gene Therapy Production Share by Regions in 2016
-
Figure USA Gene Therapy Production Share by Regions in 2021
-
Figure USA Gene Therapy Production Share by Regions in 2027
-
Table USA Gene Therapy Consumption by Regions
-
Table USA Gene Therapy Consumption Share by Regions
-
Figure USA Gene Therapy Consumption Share by Regions in 2016
-
Figure USA Gene Therapy Consumption Share by Regions in 2021
-
Figure USA Gene Therapy Consumption Share by Regions in 2027
-
Table West USA Gene Therapy Consumption by Types from 2016 to 2027
-
Table West USA Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure West USA Gene Therapy Consumption Share by Types in 2016
-
Figure West USA Gene Therapy Consumption Share by Types in 2021
-
Figure West USA Gene Therapy Consumption Share by Types in 2027
-
Table West USA Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table West USA Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Gene Therapy Consumption Share by End-Users in 2016
-
Figure West USA Gene Therapy Consumption Share by End-Users in 2021
-
Figure West USA Gene Therapy Consumption Share by End-Users in 2027
-
Table South USA Gene Therapy Consumption by Types from 2016 to 2027
-
Table South USA Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure South USA Gene Therapy Consumption Share by Types in 2016
-
Figure South USA Gene Therapy Consumption Share by Types in 2021
-
Figure South USA Gene Therapy Consumption Share by Types in 2027
-
Table South USA Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table South USA Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Gene Therapy Consumption Share by End-Users in 2016
-
Figure South USA Gene Therapy Consumption Share by End-Users in 2021
-
Figure South USA Gene Therapy Consumption Share by End-Users in 2027
-
Table Middle West USA Gene Therapy Consumption by Types from 2016 to 2027
-
Table Middle West USA Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Gene Therapy Consumption Share by Types in 2016
-
Figure Middle West USA Gene Therapy Consumption Share by Types in 2021
-
Figure Middle West USA Gene Therapy Consumption Share by Types in 2027
-
Table Middle West USA Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Gene Therapy Consumption Share by End-Users in 2016
-
Figure Middle West USA Gene Therapy Consumption Share by End-Users in 2021
-
Figure Middle West USA Gene Therapy Consumption Share by End-Users in 2027
-
Table Northeast USA Gene Therapy Consumption by Types from 2016 to 2027
-
Table Northeast USA Gene Therapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Gene Therapy Consumption Share by Types in 2016
-
Figure Northeast USA Gene Therapy Consumption Share by Types in 2021
-
Figure Northeast USA Gene Therapy Consumption Share by Types in 2027
-
Table Northeast USA Gene Therapy Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Gene Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Gene Therapy Consumption Share by End-Users in 2016
-
Figure Northeast USA Gene Therapy Consumption Share by End-Users in 2021
-
Figure Northeast USA Gene Therapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Dimension Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dimension Therapeutics
-
Figure Sales and Growth Rate Analysis of Dimension Therapeutics
-
Figure Revenue and Market Share Analysis of Dimension Therapeutics
-
Table Product and Service Introduction of Dimension Therapeutics
-
Table Company Profile and Development Status of Spark Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spark Therapeutics
-
Figure Sales and Growth Rate Analysis of Spark Therapeutics
-
Figure Revenue and Market Share Analysis of Spark Therapeutics
-
Table Product and Service Introduction of Spark Therapeutics
-
Table Company Profile and Development Status of Celladon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celladon
-
Figure Sales and Growth Rate Analysis of Celladon
-
Figure Revenue and Market Share Analysis of Celladon
-
Table Product and Service Introduction of Celladon
-
Table Company Profile and Development Status of Vical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vical
-
Figure Sales and Growth Rate Analysis of Vical
-
Figure Revenue and Market Share Analysis of Vical
-
Table Product and Service Introduction of Vical
-
Table Company Profile and Development Status of Avalanche Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avalanche Bio
-
Figure Sales and Growth Rate Analysis of Avalanche Bio
-
Figure Revenue and Market Share Analysis of Avalanche Bio
-
Table Product and Service Introduction of Avalanche Bio
-
Table Company Profile and Development Status of Advantagene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advantagene
-
Figure Sales and Growth Rate Analysis of Advantagene
-
Figure Revenue and Market Share Analysis of Advantagene
-
Table Product and Service Introduction of Advantagene
-
Table Company Profile and Development Status of Sangamo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo
-
Figure Sales and Growth Rate Analysis of Sangamo
-
Figure Revenue and Market Share Analysis of Sangamo
-
Table Product and Service Introduction of Sangamo
-
